Mixed Topics
Conference Coverage
Lower olanzapine dose just as effective for chemotherapy-induced nausea, vomiting
A 2.5-mg dose of olanzapine may be just as effective at preventing nausea and vomiting as the standard 10 mg with far less daytime drowsiness.
Feature
Where Is the ‘Microbiome Revolution’ Headed Next?
Important advances are coming our way in the next 5-10 years.
Latest News
GVHD raises vitiligo risk in transplant recipients
Graft-versus-host disease appears to raise vitiligo risk in transplant recipients, particularly those who receive hematopoietic stem cell...
Conference Coverage
Patients with HR-positive breast cancer can safely use ART
“These data are reassuring for our young patients with a diagnosis of breast cancer and shows that assisted reproductive technology is an option...
Conference Coverage
Living in a Food Swamp Tied to High Breast Cancer Mortality
New research shows higher postmenopausal breast cancer mortality in communities with easier access to unhealthy fast food.
Conference Coverage
Answering the unknowns of taxanes for breast cancer during pregnancy
Conference Coverage
CAR T-Cell Therapy: Cure for Systemic Autoimmune Diseases?
New research suggests that CAR T-cell therapy might prove to be a game-changing treatment for lupus and two other autoimmune diseases.
Conference Coverage
Relapsed DLBCL: With Complete Interim Response, SCT Outperforms CAR T
Awaiting CAR T therapy, patients with complete response to interim chemo show better outcomes with subsequent autologous transplantation, compared...
Conference Coverage
Hematology is in the Brodsky family’s blood
Three generations of Brodsky men have forged careers in the same medical field.
Conference Coverage
ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes
Leaders of the American Society of Hematology preview hot topics and presentations on tap at their 2023 annual meeting.
News
FDA approves pirtobrutinib for previously treated CLL/SLL
FDA greenlights pirtobrutinib as third-line treatment for chronic lymphocytic leukemia or small lymphocytic lymphoma in adults.